These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19910894)

  • 21. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
    Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Gao W; Jiang N; Zhu G
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):821-3. PubMed ID: 11038775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia-induced myocardial injury after coronary artery bypass.
    Thiengburanatham S
    Asian Cardiovasc Thorac Ann; 2009 Oct; 17(5):483-9. PubMed ID: 19917790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine Levels are Associated with Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients.
    Hu Y; Xu Y; Wang G
    Metab Syndr Relat Disord; 2019; 17(6):323-327. PubMed ID: 31045466
    [No Abstract]   [Full Text] [Related]  

  • 29. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperhomocysteinemia in pediatric and young adult renal transplant recipients.
    Belson A; Sanchez J; Alexander SR; Salvatierra O; Dar MH; Reif S; Yorgin PD
    Pediatr Transplant; 2004 Apr; 8(2):161-6. PubMed ID: 15049796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome.
    Maurer M; Burri S; de Marchi S; Hullin R; Martinelli M; Mohacsi P; Hess OM
    Int J Cardiol; 2010 May; 141(1):32-8. PubMed ID: 19181408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
    Dai J; Li W; Chang L; Zhang Z; Tang C; Wang N; Zhu Y; Wang X
    Free Radic Biol Med; 2006 Nov; 41(10):1566-77. PubMed ID: 17045925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats.
    Devi S; Kennedy RH; Joseph L; Shekhawat NS; Melchert RB; Joseph J
    Cardiovasc Pathol; 2006; 15(2):75-82. PubMed ID: 16533695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
    Kalita J; Kumar G; Bansal V; Misra UK
    Clin Neurol Neurosurg; 2009 May; 111(4):364-7. PubMed ID: 19185985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
    Nogueira JB
    Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of homocysteinemia in patients with congestive heart failure.
    Gibelin P; Serre S; Candito M; Houcher B; Berthier F; Baudouy M
    Clin Chem Lab Med; 2006; 44(7):813-6. PubMed ID: 16776625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
    Campolo J; Caruso R; De Maria R; Parolini M; Oliva F; Roubina E; Cighetti G; Frigerio M; Vitali E; Parodi O
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1024-8. PubMed ID: 18163014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine and arterial occlusive disease: a concise review.
    Andreotti F; Burzotta F; Mazza A; Manzoli A; Robinson K; Maseri A
    Cardiologia; 1999 Apr; 44(4):341-5. PubMed ID: 10371785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.